Cancer is a major cause of global mortality, both in affluent countries and increasingly in
develo** nations. Many patients with cancer experience reduced life expectancy and …

With a 3‐fold increase in the number of cancer survivors noted since the 1970s, there are
now over 28 million cancer survivors worldwide. Accordingly, there is a heightened …

Abstract The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …

Objective The contemporary diagnosis of paraneoplastic neurologic syndromes (PNSs)
requires an increasing understanding of their clinical, immunologic, and oncologic …

Background The epidemiology of paraneoplastic neurological syndromes (PNS) remains to
be defined. We present here the first population-based incidence study and report the …

Paraneoplastic neurological syndromes (PNS) are the immune-mediated effects of a remote
cancer and are characterised by an autoantibody response against antigens expressed by …

The concept of antibody mediated CNS disorders is relatively recent. The classical CNS
paraneoplastic neurological syndromes are thought to be T cell mediated, and the …

Paraneoplastic neurological syndromes (PNSs) are rare complications of systemic cancers
that can affect all parts of the central and/or peripheral nervous system. A body of …

Recently, several autoimmune neurological diseases have been defined by the presence of
autoantibodies against different antigens of the nervous system. These autoantibodies have …

In the last few years, a lot of publications suggested that disabling cerebellar ataxias may
develop through immune-mediated mechanisms. In this consensus paper, we discuss the …